Show simple item record

dc.contributor.authorKaur R.P.
dc.contributor.authorRubal
dc.contributor.authorBanipal R.P.S.
dc.contributor.authorVashistha R.
dc.contributor.authorDhiman M.
dc.contributor.authorMunshi A.
dc.date.accessioned2020-01-31T11:33:58Z
dc.date.available2020-01-31T11:33:58Z
dc.date.issued2019
dc.identifier.issn1470272
dc.identifier.urihttp://kr.cup.edu.in/handle/32116/2547
dc.description.abstractBackground and Purpose: Inflammation and caner are linked in a bidirectional manner. C-reactive protein (CRP) is an important inflammatory marker. The aim of the study was to test whether the inflammatory marker, CRP at the time of diagnosis of breast cancer is associated with metastasis, recurrence, and death in breast cancer patients from Malwa region of Punjab where breast cancer is widely feared. Material and Methods: Two hundred and forty-two breast cancer patients and 242 age and sex matched controls were included in the study. CRP levels were estimated using fully automated bio analyzer Erba200. Follow up interviews were conducted at an interval of 3, 6, 9, 12, 15, 18, 21, 24, and 27 months to determine the outcome among breast cancer patients. Results: Elevated levels of CRP were found among the diseased in comparison with controls (P < 0.0001). Higher CRP levels associated significantly with poor outcome including metastasis and recurrence among breast cancer patients [P = 0.03; 95% confidence interval; odds ratio: 2.954 (0.9125-9.561)]. Conclusion: Elevated levels of CRP associated significantly with increased risk of breast cancer and poor outcome. CRP estimation may be a simple and inexpensive tool for the risk assessment and outcome of the disease in Malwa region of Punjab where incidence of breast cancer is reported to be very high.en_US
dc.language.isoen_USen_US
dc.publisherMosby Inc.en_US
dc.subjectBreast canceren_US
dc.subjectC-reactive proteinen_US
dc.subjectInfiltrating ductal carcinomaen_US
dc.subjectMetastasisen_US
dc.subjectRecurrenceen_US
dc.titleAssociation of elevated levels of C-reactive protein with breast cancer, breast cancer subtypes, and poor outcomeen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.currproblcancer.2018.05.003
dc.identifier.urlhttps://www.sciencedirect.com/science/article/abs/pii/S0147027218301053?via%3Dihub
dc.title.journalCurrent Problems in Canceren_US
dc.type.accesstypeClose Accessen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record